Europe Bioproduction Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Bioproduction Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Bioproduction Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Bioproduction Market Regional Analysis

6.2 Europe Bioproduction Market Revenue 2020-2030 (US$ Million)

6.3 Europe Bioproduction Market Forecast Analysis

7. Europe Bioproduction Market Analysis – by Product

7.1 Biologics and Biosimilars

7.1.1 Overview
7.1.2 Biologics and Biosimilars: Europe Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.2 Vaccines

7.2.1 Overview
7.2.2 Vaccines: Europe Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.3 Cell and Gene Therapies

7.3.1 Overview
7.3.2 Cell and Gene Therapies: Europe Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.4 Nucleic Acid Therapeutics

7.4.1 Overview
7.4.2 Nucleic Acid Therapeutics: Europe Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. Europe Bioproduction Market Analysis – by Application

8.1 Rheumatoid Arthritis

8.1.1 Overview
8.1.2 Rheumatoid Arthritis: Europe Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.2 Hematological Disorders

8.2.1 Overview
8.2.2 Hematological Disorders: Europe Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.3 Cancer

8.3.1 Overview
8.3.2 Cancer: Europe Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.4 Diabetes

8.4.1 Overview
8.4.2 Diabetes: Europe Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.5 Cardiovascular Diseases

8.5.1 Overview
8.5.2 Cardiovascular Diseases: Europe Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. Europe Bioproduction Market Analysis – by Equipment

9.1 Upstream Equipment

9.1.1 Overview
9.1.2 Upstream Equipment: Europe Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.2 Downstream Equipment

9.2.1 Overview
9.2.2 Downstream Equipment: Europe Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.3 Bioreactors

9.3.1 Overview
9.3.2 Bioreactors: Europe Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.4 Consumables and Accessories

9.4.1 Overview
9.4.2 Consumables and Accessories: Europe Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. Europe Bioproduction Market Analysis – by End User

10.1 Biopharmaceutical Companies

10.1.1 Overview
10.1.2 Biopharmaceutical Companies: Europe Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.2 Contract Manufacturing Organizations

10.2.1 Overview
10.2.2 Contract Manufacturing Organizations: Europe Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)

11. Europe Bioproduction Market – Europe Analysis

11.1 Overview

11.2 Europe

11.2.1 Europe Bioproduction Market Breakdown, by Key Country, 2023 and 2030 (%)
11.2.1.1 Europe Bioproduction Market – Revenue and Forecast Analysis – by Country
11.2.1.1 UK: Europe Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.1.1 UK: Europe Bioproduction Market Breakdown, by Product
11.2.1.1.2 UK: Europe Bioproduction Market Breakdown, by Application
11.2.1.1.3 UK: Europe Bioproduction Market Breakdown, by Equipment
11.2.1.1.4 UK: Europe Bioproduction Market Breakdown, by End User

11.2.1.2 Germany: Europe Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.2.1 Germany: Europe Bioproduction Market Breakdown, by Product
11.2.1.2.2 Germany: Europe Bioproduction Market Breakdown, by Application
11.2.1.2.3 Germany: Europe Bioproduction Market Breakdown, by Equipment
11.2.1.2.4 Germany: Europe Bioproduction Market Breakdown, by End User

11.2.1.3 France: Europe Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.3.1 France: Europe Bioproduction Market Breakdown, by Product
11.2.1.3.2 France: Europe Bioproduction Market Breakdown, by Application
11.2.1.3.3 France: Europe Bioproduction Market Breakdown, by Equipment
11.2.1.3.4 France: Europe Bioproduction Market Breakdown, by End User

11.2.1.4 Russia: Europe Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.4.1 Russia: Europe Bioproduction Market Breakdown, by Product
11.2.1.4.2 Russia: Europe Bioproduction Market Breakdown, by Application
11.2.1.4.3 Russia: Europe Bioproduction Market Breakdown, by Equipment
11.2.1.4.4 Russia: Europe Bioproduction Market Breakdown, by End User

11.2.1.5 Italy: Europe Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.5.1 Italy: Europe Bioproduction Market Breakdown, by Product
11.2.1.5.2 Italy: Europe Bioproduction Market Breakdown, by Application
11.2.1.5.3 Italy: Europe Bioproduction Market Breakdown, by Equipment
11.2.1.5.4 Italy: Europe Bioproduction Market Breakdown, by End User

11.2.1.6 Rest of Europe: Europe Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.6.1 Rest of Europe: Europe Bioproduction Market Breakdown, by Product
11.2.1.6.2 Rest of Europe: Europe Bioproduction Market Breakdown, by Application
11.2.1.6.3 Rest of Europe: Europe Bioproduction Market Breakdown, by Equipment
11.2.1.6.4 Rest of Europe: Europe Bioproduction Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 bbi-biotech GmbH

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Bio-Rad Laboratories Inc

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Danaher Corp

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 F. Hoffmann-La Roche Ltd

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 FUJIFILM Irvine Scientific Inc

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Lonza Group AG

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Merck KGaA

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Sartorius AG

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Thermo Fisher Scientific Inc

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Europe Bioproduction Market